Andrew A. Krakauer
Director
pharmaceutical
Teleflex
China
Biography
on December 11, 2017, the Board elected Andrew Krakauer to serve as a director of the company effective January 1, 2018. Prior to his retirement in October 2016, Mr. Krakauer, 62, was Chief Executive Officer of Cantel Medical Corp. (Cantel), a provider of infection control products and services. During his 12 years at Cantel, Mr. Krakauer served in various executive and senior level positions, including Chief Executive Officer from November 2014 to July 2016; President and Chief Executive Officer from March 2009 to November 2014; President from April 2008 to March 2009; and Executive Vice President and Chief Operating Officer from August 2004 through April 2008. Mr. Krakauer also served as a member of Cantel's board of directors from 2009 to 2016. Prior to joining Cantel, Mr. Krakauer was President of the Ohmeda Medical Division of Instrumentarium Corp. (which was acquired by General Electric Company in 2003), a provider of medical devices, from 1998 to 2004.
Research Interest
pharmaceutical
